【摘要】 目的观察α1A受体阻滞剂治疗慢性前列腺炎的疗效。方法80例慢性前列腺炎患者被随机分为A、B两组,分别应用左氧氟沙星(A组)、α1A受体阻滞剂坦索络新和左氧氟沙星(B组)。观察其疗效并进行统计学分析。结果B组治疗前后前列腺症状评分(SFQ)、前列腺液常规、尿流率的改善率明显优于A组(P<0.01)。结论α1A受体阻滞剂对慢性前列腺炎有明显的治疗作用,可作为治疗慢性前列腺炎的有效药物。更多还原

【Abstract】 Objective: To evaluate therapeutic efficacy of inhibitors of α1A-receptor(tamsulosin) in chronic prostatitis.Methods: Eighty cases were divided into A and B groups randomly,and treated differently as the following.Cases of group A were treated with levofloxacin only and group B with tamsulosin and levofloxacin.Symptom frequency questionnaire(SFQ),prostaticus,uroflow were observed before therapy and 6 weeks after therapy.The cure rate was analysed statistically.Results: In 18 cases(56.25%) of group A,the symptom disappeared or improved,in 17 cases(33.13%),SFQ improved and in 15cases(46.88%),WBC disappeared or lowered in EPS.In group B,the number was 32(88.89%),33(91.67%) and 30(83.33%).Conclusion: Inhibitors of a1A-receptor has obvious therapeatic efficacy in CP,bacterial or nonbacterial,and can be an effective drug for them.更多还原